Cravatex Q1 Results: Consolidated profit turns positive, revenue up 39%

1 min read     Updated on 12 Aug 2026, 07:49 PM
scanx
Reviewed by
Naman SScanX News Team
AI Summary

Cravatex Ltd posted a consolidated net profit of ₹43.81 lakh in Q1FY27, reversing a ₹136.77 lakh loss from Q1FY26. Consolidated revenue grew 39% YoY to ₹3,222.45 lakh. The profit turnaround was aided by a ₹202.36 lakh positive inventory adjustment at the group level, offsetting higher operational costs.

powered bylight_fuzz_icon
48089957

*this image is generated using AI for illustrative purposes only.

Cravatex Limited reported a consolidated net profit of ₹43.81 lakh for the quarter ended June 30, 2026, marking a return to profitability after recording a net loss of ₹136.77 lakh in the same period of FY26. This improvement coincided with a 39% year-on-year rise in consolidated revenue from operations to ₹3,222.45 lakh, up from ₹2,312.69 lakh in Q1FY26.

The Board of Directors approved the unaudited standalone and consolidated financial results on August 12, 2026. GPS & Associates served as the statutory auditors, issuing an unmodified limited review report on the statements prepared in accordance with Ind AS.

Financial Performance

Consolidated total income reached ₹3,662.63 lakh, driven by operating revenue and other income of ₹440.18 lakh. While purchase of stock-in-trade increased to ₹1,799.53 lakh, a favorable change in inventories of stock-in-trade amounting to ₹(202.36) lakh significantly reduced total expenses to ₹3,595.70 lakh.

Metric: Q1FY27 (Consolidated): Q1FY26 (Consolidated): Change:
Revenue from Operations: ₹3,222.45 lakh ₹2,312.69 lakh +39.3%
Total Income: ₹3,662.63 lakh ₹2,833.65 lakh +29.3%
Total Expenses: ₹3,595.70 lakh ₹2,969.81 lakh +21.1%
Net Profit/(Loss): ₹43.81 lakh ₹(136.77) lakh Turnaround
EPS (Basic): ₹1.70 ₹(5.29) N/A

On a standalone basis, Cravatex reported a net profit of ₹41.08 lakh, compared to ₹44.21 lakh in Q1FY26. Standalone revenue remained flat at ₹144.49 lakh. Other income contributed ₹139.64 lakh to standalone total income, which stood at ₹284.13 lakh.

What the Numbers Show

A notable divergence exists between the standalone and consolidated results regarding inventory management. While the standalone entity reported no change in inventories, the consolidated group recorded a positive adjustment of ₹202.36 lakh in the change in inventories of stock-in-trade. This favorable inventory movement was a key factor in narrowing the gap between total income and total expenses at the group level, enabling the turnaround to profit despite higher employee benefits expense (₹740.54 lakh vs ₹741.92 lakh) and other expenses (₹1,211.98 lakh vs ₹857.77 lakh) compared to the prior year quarter.

Historical Stock Returns for Cravatex

1 Day5 Days1 Month6 Months1 Year5 Years
-0.09%-2.81%-14.20%-5.94%-26.81%+16.37%

Will Cravatex be able to sustain its profitability in Q2FY27 given that the Q1 turnaround was largely driven by a one-time favorable inventory adjustment rather than core operational efficiency?

How does the significant divergence between flat standalone revenue and a 39% surge in consolidated revenue reflect the financial health and contribution of Cravatex's subsidiaries?

With other income contributing substantially to standalone total income (₹139.64 lakh), what is the sustainability of these non-operating gains in future quarters?

Cravatex shareholders approve ₹13 dividend, reappoint Rajesh Batra

2 min read     Updated on 03 Aug 2026, 02:36 PM
scanx
Reviewed by
Ashish TScanX News Team
AI Summary

Cravatex Limited's 74th AGM resulted in the approval of a ₹13 final dividend for FY26 and the reappointment of Director Rajesh Batra. All resolutions passed with 99.70% support, driven by full promoter participation. The meeting complied with SEBI and MCA regulations, with NSDL facilitating e-voting.

powered bylight_fuzz_icon
47293563

*this image is generated using AI for illustrative purposes only.

Cravatex Limited shareholders have approved a final dividend of ₹13 per equity share, representing a 130% payout for the financial year ended March 31, 2026, alongside the reappointment of Director Rajesh Batra. The decisions were ratified at the company’s 74th Annual General Meeting (AGM) held on July 31, 2026, with all three ordinary resolutions securing overwhelming support from voting shareholders.

The meeting was conducted through Video Conferencing (VC) or Other Audio Visual Means (OAVM) in compliance with Ministry of Corporate Affairs (MCA) circulars and Securities and Exchange Board of India (SEBI) regulations. Voting was facilitated by National Securities Depositories Limited (NSDL), with remote e-voting open from July 28 to July 30, 2026. Hemanshu Kapadia & Associates served as the scrutinizer for the process.

Voting Results Overview

A total of 2,037,204 votes were polled out of 2,584,160 shares held by eligible shareholders as of the record date, July 24, 2026. This represents a participation rate of 78.83% among those entitled to vote. Promoter and promoter group entities held 1,938,120 shares and voted in favor of all resolutions, while public non-institutional shareholders held 646,040 shares.

Resolution Description Votes in Favor Votes Against % Support
Adoption of Audited Financial Statements for FY26 2,031,182 6,022 99.70%
Declaration of Final Dividend of ₹13 per share 2,031,182 6,022 99.70%
Reappointment of Director Rajesh Batra 2,031,182 6,022 99.70%

Key Resolutions Passed

The first resolution concerned the adoption of the audited financial statements for FY26, including the balance sheet, statement of profit and loss, and cash flow statement, along with the reports of the Board of Directors and auditors. This resolution passed with 99.70% affirmative votes.

The second resolution authorized the declaration of the final dividend. The ₹13 per share payout is significant for income-focused investors, marking a substantial return on capital for the fiscal year. No promoter interest was declared in this agenda item.

The third resolution involved the reappointment of Mr. Rajesh Batra (DIN 00020764), who retired by rotation and offered himself for re-election. The Board recommended his reappointment, which was approved by the shareholders with identical voting patterns to the other resolutions.

Compliance and Scrutiny

The voting process adhered to Section 108 of the Companies Act, 2013, Rule 20 of the Companies (Management and Administration) Rules, 2014, and Secretarial Standard-2 (SS-2) issued by the Institute of Company Secretaries of India. The scrutinizer confirmed that votes were unblocked in the presence of two independent witnesses, Ms. Preeti Bhangle and Ms. Diksha Gupta, ensuring procedural integrity. The notice for the AGM was dispatched on July 1, 2026, following the MCA circular dated September 22, 2025.

Historical Stock Returns for Cravatex

1 Day5 Days1 Month6 Months1 Year5 Years
-0.09%-2.81%-14.20%-5.94%-26.81%+16.37%

How sustainable is the 130% dividend payout ratio for Cravatex Limited given its current cash reserves and projected capital expenditure plans for FY27?

What specific strategic initiatives or operational improvements is Director Rajesh Batra expected to lead during his reappointed term?

Will the high dividend yield attract increased institutional investment, or might it signal a lack of high-growth reinvestment opportunities for the company?

More News on Cravatex

1 Year Returns:-26.81%